Monitor for potential downward pressure on shares; coordinated insider selling—especially by the CEO and a director—above $300K each may signal lack of confidence despite routine tax events among other executives. Watch for commentary on liquidity or future selling plans in upcoming earnings.
Price Chart
Executive Summary
Three corporate insiders at Kiniksa Pharmaceuticals sold shares in open-market transactions totaling $789K over a 7-day window, including CEO Sanj Patel selling $364K and Director Barry Quart selling $345K. The sales follow routine tax-related dispositions and derivative exercises by other C-suite executives, suggesting coordinated post-vesting activity.
Key Financial Metrics
Key Facts
- CEO Sanj Patel sold $364K in open-market transactions on 2026-04-06
- Director Barry Quart sold $345K in open-market transactions on 2026-04-06
- COO Ross Moat sold $80K in open-market shares on 2026-04-09
- Total open-market selling by insiders: $789K
- Multiple C-suite executives also conducted non-cash transactions (exercises, tax withholding) around the same date
Financial Impact
$789,000 in open-market insider selling over 7 days
Risk Factors
- Perceived negative signal from CEO and director selling significant amounts in open market
- Potential for short-term share price sensitivity given the concentrated timing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KNSA-1776112522811 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $80.79 | awaiting T+60 | — | $70.72 (−12.46%) |
Oct 22, 2026 3d ago | Press Release | $80.79 | awaiting T+60 | — | $70.72 (−12.46%) |
Sep 3, 2026 7w ago | 144 | $77.91 | awaiting T+60 | — | $70.72 (−9.22%) |
Jul 28, 2026 12w ago | 8-K | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $70.72 (−10.97%) |
Jul 28, 2026 12w ago | Press Release | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $70.72 (−10.97%) |
May 26, 2026 21w ago | 8-K | $51.84 $78.47 | ▲ +51.37% | ▲ +49.49% | $70.72 (+36.43%) |
May 1, 2026 25w ago | 8-K | $57.62 $80.92 | ▲ +40.44% | ▲ +38.58% | $70.72 (+22.74%) |
Apr 28, 2026 25w ago | 144 | $52.99 $62.84 | ▼ −18.59% | ▼ −14.48% | $70.72 (−33.47%) |
Apr 28, 2026 25w ago | Press Release | $53.85 $63.05 | ▲ +17.08% | ▲ +13.10% | $70.72 (+31.33%) |
Apr 28, 2026 25w ago | Insider Cluster | $53.85 $63.05 | ▲ +17.08% | ▲ +13.10% | $70.72 (+31.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers